Stay updated with breaking news from Eric Ducournau. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
19.12.2022 - Atara Biotherapeutics, Inc. (Nasdaq: ATRA) and Pierre Fabre today announced that the European Commission (EC) has granted marketing authorization for Ebvallo (tabelecleucel) as a monotherapy for the treatment of adult and pediatric patients two ... Seite 1
/PRNewswire/ -- Yatsen Global debuted the latest innovations of its premium technology-oriented skin care brand Galenic, and EVE LOM, a high-end natural SPA...
SHANGHAI, Nov. 10, 2022 /PRNewswire/ -- Yatsen Global debuted the latest innovations of its premium technology-oriented skin care brand Galenic, and EVE LOM, a high-end natural SPA brand from
EbvalloTM on Track to be the First Ever Allogeneic T-Cell Therapy Approved Positive Opinion Based on Pivotal Phase 3 ALLELE Study Demonstrating a Favorable Risk-Benefit Profile European Commission
EbvalloTM on Track to be the First Ever Allogeneic T-Cell Therapy Approved Positive Opinion Based on Pivotal Phase 3 ALLELE Study Demonstrating a Favorable Risk-Benefit Profile European